菊科植物作为糖尿病治疗方法的潜在用途:从民族药理学至现代药物及营养保健品研发的综述
Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments.
作者信息
Mohanta Yugal Kishore, Mishra Awdhesh Kumar, Nongbet Amilia, Chakrabartty Ishani, Mahanta Saurov, Sarma Bhaskar, Panda Jibanjyoti, Panda Sujogya Kumar
机构信息
Nano-biotechnology and Translational Knowledge Laboratory, Department of Applied Biology, School of Biological Sciences, University of Science and Technology Meghalaya (USTM), Techno City, Meghalaya, India.
Centre for Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, kelambakkam, Tamil Nadu, India.
出版信息
Front Pharmacol. 2023 Aug 3;14:1153600. doi: 10.3389/fphar.2023.1153600. eCollection 2023.
The diabetesassociated mortality rate is increasing annually, along with the severity of its accompanying disorders that impair human health. Worldwide, several medicinal plants are frequently urged for the management of diabetes. Reports are available on the use of medicinal plants by traditional healers for their blood-sugar-lowering effects, along with scientific evidence to support such claims. The Asteraceae family is one of the most diverse flowering plants, with about 1,690 genera and 32,000 species. Since ancient times, people have consumed various herbs of the Asteraceae family as food and employed them as medicine. Despite the wide variety of members within the family, most of them are rich in naturally occurring polysaccharides that possess potent prebiotic effects, which trigger their use as potential nutraceuticals. This review provides detailed information on the reported Asteraceae plants traditionally used as antidiabetic agents, with a major focus on the plants of this family that are known to exert antioxidant, hepatoprotective, vasodilation, and wound healing effects, which further action for the prevention of major diseases like cardiovascular disease (CVD), liver cirrhosis, and diabetes mellitus (DM). Moreover, this review highlights the potential of Asteraceae plants to counteract diabetic conditions when used as food and nutraceuticals. The information documented in this review article can serve as a pioneer for developing research initiatives directed at the exploration of Asteraceae and, at the forefront, the development of a botanical drug for the treatment of DM.
糖尿病相关死亡率逐年上升,同时其伴随疾病的严重程度也在增加,这些疾病损害人类健康。在全球范围内,几种药用植物常被用于糖尿病的管理。有报道称传统治疗师使用药用植物来降低血糖,同时也有科学证据支持这些说法。菊科是最多样化的开花植物科之一,约有1690属和32000种。自古以来,人们就食用菊科的各种草药作为食物,并将它们用作药物。尽管该科成员种类繁多,但它们大多富含具有强大益生元作用的天然多糖,这促使它们被用作潜在的营养保健品。本综述提供了关于传统上用作抗糖尿病药物的菊科植物的详细信息,主要关注已知具有抗氧化、保肝、血管舒张和伤口愈合作用的该科植物,这些作用对预防心血管疾病(CVD)、肝硬化和糖尿病(DM)等重大疾病有进一步作用。此外,本综述强调了菊科植物用作食物和营养保健品时对抗糖尿病状况的潜力。这篇综述文章中记录的信息可以作为开展针对菊科探索的研究计划的先驱,并在最前沿开发用于治疗糖尿病的植物药。